Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Addex Therapeutics Ltd    ADXN   CH0029850754

 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
05/19/2017 05/22/2017 05/23/2017 05/24/2017 05/26/2017 Date
2.47(c) 2.46(c) 2.46(c) 2.44(c) 2.45(c) Last
45 300 8 998 11 188 12 367 8 026 Volume
0.00% -0.40% 0.00% -0.81% +0.41% Change
More quotes
Company
Addex Therapeutics Ltd. is a biopharmaceutical company engages in the development of novel, orally available, small molecule allosteric modulators for neurological disorders.The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva,... 
More about the company
Latest news on ADDEX THERAPEUTICS LTD
05/10 ADDEX THERAPEUTICS : ADX71441 Demonstrates Preclinical Analgesic Effects
05/09 ADDEX THERAPEUTICS : ADX71441 Demonstrates Preclinical Analgesic Effects
05/04 ADDEX THERAPEUTICS : ADX71441 Preclinical Results for Treatment of Alcohol Use D..
04/05 ADDEX THERAPEUTICS : Provides Corporate Update and Reports 2016 Financial Result..
04/05 ADDEX THERAPEUTICS : Provides Corporate Update and Reports 2016 Financial Result..
03/01 ADDEX THERAPEUTICS : Raises CHF3.0 million Through Private Placement of Treasury..
02/28 ADDEX THERAPEUTICS : `s ADX71149 Anti-Epileptic Effect Highlighted in Scientific..
02/28 ADDEX THERAPEUTICS : Raises CHF3.0 million Through Private Placement of Treasury..
02/27 ADDEX THERAPEUTICS : ADX71149 Anti-Epileptic Effect Highlighted in Scientific Jo..
02/27 ADDEX THERAPEUTICS : ADX71149 Anti-Epileptic Effect Highlighted in Scientific Jo..
More news
Sector news : Biotechnology & Medical Research - NEC
05/23 UK competition watchdog accuses Merck of obstructing biosimilars
05/22 Cross-border M&A between U.S. and European firms at 10 year high
05/22DJAMGEN : Another Gloomy Day for Amgen
05/09 Sanofi pegs U.S. drug price rises to below healthcare inflation
05/09DJVERTEX PHARMACEUTICALS INCORPORATED : Trump's Pick to Lead FDA Has Backing of Bi..
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
05/09Addex Therapeutics ADX71441 Demonstrates Preclinical Analgesic Effects  
04/05Addex Therapeutics Provides Corporate Update And Reports 2016 Financial Resul.. 
2016Addex Therapeutics : ADX71441 Pharmacological Profile Published in Neuropharm.. 
2016Addex Therapeutics Biopharmaceutical Industry Veteran, As Chief Medical Offic.. 
2016Addex Therapeutics : Appoints Biopharmaceutical Industry Veteran, Roger G. Mi.. 
More tweets
Qtime:4
Advertisement
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | ADXN | CH0029850754 | 4-Traders
Full-screen chart
Technical analysis trends ADDEX THERAPEUTIC...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Managers
NameTitle
Timothy Dyer Chief Executive Officer & Director
Vincent M. Lawton Chairman
Sonia Maria Poli Chief Scientific Officer & Head-Development
Roger G. Mills Chief Medical Officer
Raymond George Hill Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ADDEX THERAPEUTICS LTD33.15%34
INCYTE CORPORATION38.04%27 518
QUINTILES IMS HOLDINGS..11.37%18 872
LONZA GROUP AG25.78%15 703
CELLTRION, INC.--.--%10 293
SEATTLE GENETICS, INC.25.11%9 358
More Results